* Go To Z101.COM *                 ** Jobs & Useful Links **   FIRE101 Fire Jobs    POLICE101 Jobs  Computer Mainframe Jobs Obituaries101 Accident Lawyers101 FIRE101  FIRE101 MOBILE POLICE101 Protect101 School Directions   ** Car Websites **   Corvettes 101   Mustangs 101 New Cars 101 Luxury Cars 101 Exotic Cars 101   ** Sports Websites ** Lacrosse 101 Volleyball 101 Cross Country 101 Rowing 101 Rugby 101 Softball 101 Water Polo 101 Karate 101 TKD 101   ** Medical Websites ** Internal Medicine 101 Sports Medicine 101 Pharmacology 101   Gastroenterology 101 Geriatrics 101 Hepatology 101 Nephrology 101 Neurology101 Nursing 101 OccupationalTherapy101 Orthopedics 101 Pathology101 Podiatry 101 Psychiatry 101 Rheumatology 101 Urology 101   Diseases 101 Depression 101 Lyme Disease 101 OCD101   ** Lawyers Websites ** * Find Lawyers 101 * Accident Lawyers 101 Bankruptcy Lawyers 101 Defense Lawyers 101 Divorce Lawyers 101 DWI Lawyers 101 Malpractice Lawyers 101 Patent Lawyers 101 Personal Injury Lawyers 101 Probate Lawyers 101 Real Estate Lawyers 101 Tax Lawyers 101   ** Computer Websites **   zOS101   z/OS Jobs    Predictive Analytics 101   zVM101   DB2101   CICS101   MVS101   CRM101   ECM101   ERP101   Project Management   Quality Assuance 101   Disaster Recovery 101   Mainframes101   Software101     ** Most Popular Pages **  * Z101 *  Volleyball101 NEWS Lacrosse101 Fuel Cell Fuel Cell Technology Bridgeport CT Fuel Cell Parks Power Plants Obama Energy Renewable Energy Green Energy Energy Alternative Fuel Hydrogen Hydrogen Fuel Cell BioFuel Methane Methanol Fuel Methanol Waste Water Fuel Cell Cars Hydrigen Powered Cars Alternative Fuel Vehicles Fuel Cell Research Fuel Cell Patent International Asia Korea Canada Germany Japan USA

* Internet Search Results    *** Search Filter: "Louisiana"    Reviewing MAESTRO-NASH and the implications for hepatology and health ... A group of patients with possible MetALD was identified in the MAESTRO-NASH trial based on carbohydrate deficient transferrin or PETH testing and their response to resmetirom was compared to those ... Reviewing MAESTRO-NASH and the implications for hepatology and ... - Nature In the 75 (9.6%) of patients with possible MetALD, the response rates to resmetirom were 29–35% for NASH resolution and 30 –35% for fibrosis improvement, similar to those without MetALD40. Relationship of non-invasive measures with histological response in ... MAESTRO-NASH (NCT03900429) is an ongoing 54-month, randomized, double-blind, placebo-controlled Phase 3 trial evaluating the efficacy of resmetirom in patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and fibrosis. 966 patients were randomized 1:1:1 to resmetirom 80mg, 100mg, or placebo administered once daily. Resmetirom for Steatotic Liver Disease: Does Data Support Widespread ... Metabolic dysfunction-associated steatohepatitis with significant fibrosis is the aggressive form of steatotic liver disease that can progress to cirrhosis and its complications. Resmetirom is a liver-directed thyroid hormone receptor beta agonist that recently received accelerated approval by the FDA based on the results of the MAESTRO trial that demonstrated reasonable safety and efficacy in ... Phosphatidylethanol in steatotic liver disease - ScienceDirect This is of specific interest in MASH trials, where multiple potential treatments have failed in phase II and III trials despite showing promise in earlier drug development phases. 118 A post hoc analysis of PEth in a selected group of participants from the MAESTRO-NASH trial has already shown that 10% had possible MetALD (PEth >20 ng/ml) within ... Effects of Resmetirom on Metabolic- Dysfunction Associated ... Background: MAESTRO- NASH, a randomised, double- blind, placebo- controlled, 54- month phase 3 trial evaluating the effi-cacy of resmetirom in patients with biopsy- confirmed metabolic- dysfunction associated steatohepatitis (MASH) and liver fibro-sis achieved primary endpoints of MASH resolution with no worsening of fibrosis, and ≥ 1- stage ... Madrigal to Present New Data from the Company’s MASH ... - BioSpace “At this year’s Liver Meeting, Madrigal will present important new data that reinforce our confidence in Rezdiffra’s potential, if approved in this indication, to benefit even the most advanced patients with compensated cirrhosis, a population we are studying in the ongoing, fully enrolled Phase 3 MAESTRO-NASH-OUTCOMES trial. Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO ... The first analysis of Rezdiffra treatment in MetALD included 75 patients from the Phase 3 MAESTRO-NASH study who were believed to have significant alcohol consumption in addition to NASH. Expert Panel Recommendations: Practical Clinical Applications for ... Metabolic dysfunction–associated steatotic liver disease affects 1 in 4 people in the United States and western Europe, with an important proportion developing metabolic dysfunction–associated steatohepatitis (MASH), the progressive subtype of metabolic dysfunction–associated steatotic liver disease. Cirrhosis caused by MASH is a leading indication for liver transplantation and the most ... The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker ... Using 2 large, population-based cohorts with available phosphatidylethanol (PEth) measurements, we developed and validated the MetALD-ALD Prediction Index (MAPI), a novel, accurate, and scalable indirect alcohol biomarker panel for distinguishing individuals with MetALD-ALD from metabolic dysfunction-associated steatotic liver disease. MAPI may guide confirmatory PEth testing in clinical ...     * Live EBAY Auctions  Get a job now! 1000s of New Jobs!  * Click on any Job to see new listings:  FIRE101 Jobs     Firemen, Volunteer FD      EMT, EMS, Emergency,     Firefighters, Chief, Rescue    POLICE101 Jobs    Police Officers, Security     Law Enforcement, Cops     Forensics, Investigation    Medical Jobs    Doctors, Nurses, ER    Hospital, Heal*th Care  Mainframe, IT jobs    z/OS, zVM, DB2, CICS    COBOL, Assembler         z Systems Programmers    Customer Support, LVL1     Project Manager, QA Test    Finance Jobs    Accounting,  Interns,    Analysts, Financial    Marketing, Investment     * Latest FUEL CELL 101 News        *** News Filter: "Louisiana"     >> Sorry... the news is not available now.        Please try again later... Thank you! >> DON"T FORGET to visit our new  Z101 Main 101 Menu Site for lots more 101 Sites!    * Click here now ==> Z101 >> Also try these popular links: Fuel Cell Fuel Cell Technology Bridgeport CT Fuel Cell Parks Power Plants Obama Energy Renewable Energy Green Energy Energy Alternative Fuel Hydrogen Hydrogen Fuel Cell BioFuel Methane Methanol Fuel Methanol Waste Water Fuel Cell Cars Hydrigen Powered Cars Alternative Fuel Vehicles Fuel Cell Research Fuel Cell Patent Fuel Cell Batteries Platinum Windfarm Solar Energy Seminar Exposition Exhibit Events Image Photo Pics Books Video AK AL AR AZ CA CO CT DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY International Asia Korea Canada Germany Japan USA      Get a job now! 1000s of New Jobs!  * Click on any Job to see new listings:  FIRE101 Jobs     Firemen, Volunteer FD      EMT, EMS, Emergency,     Firefighters, Chief, Rescue    POLICE101 Jobs    Police Officers, Security     Law Enforcement, Cops     Forensics, Investigation    Medical Jobs    Doctors, Nurses, ER    Hospital, Heal*th Care  Mainframe, IT jobs    z/OS, zVM, DB2, CICS    COBOL, Assembler         z Systems Programmers    Customer Support, LVL1     Project Manager, QA Test    Finance Jobs    Accounting,  Interns,    Analysts, Financial    Marketing, Investment